(A-E) Temporal pattern of food intake and locomotor activity. Both AraC-treated male (A) and female (B) mice showed elevated food intake specifically during the light period, whereas night-time feeding remained indifferent between groups. Locomotor activity was significantly reduced at night in AraC-treated females, whereas males showed only a trend in this regard (C, D) . Traces show the 24 hr pattern of food intake, or activity averaged across 9 consecutive days (post-surgery day 33 to 42). Bar graphs depict day/night hourly averages of food intake (A, B) and activity (C, D), or total 24 h-locomotor activity (E). n = 4, **p <0.01, ***p < 0.001, paired t test; #p <0.05, ##p <0.01, ###p < 0.001, unpaired t test; n.s., not significant. Shown are mean ± SEM. (F-J) Running wheel activity analysis of aCSF-and AraC-infused animals in constant darkness. One day post icvsurgery, animals were provided with a running wheel and transferred to constant darkness (F). Animals were infused with aCSF or AraC for one week. Activity recording started on the first day of running wheel access. (G, H) Representative double-plotted actograms of running wheel activity in aCSF-infused mice (G) or AraC-infused mice which exhibited excessive weight gain (gainers, H). (I, J) Circadian locomotor activity period (I) and circadian amplitude (power from periodogram analyses) (J) in controls and AraC-infused gainers; ns, not significant; unpaired t test; n = 5-6; mean ± SEM. Shown are mean ± SEM of the resting membrane potential (G), fast after-hyperpolarisation potential (H), membrane resistance (I), membrane capacitance (J), action potential amplitude (K), action potential duration (L) and maximum voltage (M); for all parameters tested no significant difference were found; unpaired t test; n = 6-8. (N-P) Attenuated anorexigenic response to leptin in AraC-treated ob/ob mice at 14 days following icv infusion. AraCand aCSF-infused ob/ob mice received i.p. leptin, vehicle, or MTII 1 hr before the dark cycle onset and overnight food intake was measured. Food intake is given in grams (N) or relative to prior vehicle treatment (in %, O). (P) Body weights of AraC and vehicle treated ob/ob mice. Red bar indicates infusion period. n = 6-9; **p<0.01, *p<0.05, unpaired t test; ns, not significant. Mean ± SEM. (D, E) X-irradiation led to a significant reduction in ME NG2-glia, when assessed 7 days post treatment initiation. *p<0.05, unpaired t test. n = 3-5, mean ± SEM. (F, G) Body weights (F) and composition (G) of sham-and x-irradiated female mice. Body composition was determined at post-irradiation day 10 (G, top) and 178 (G, bottom). Fat, but not lean, mass of mitotic blocker treated animals was significantly elevated. n = 5-10; *p<0.05, **p<0.01, unpaired t test, mean ± SEM. (H-M) Images of the ME from sham-(H-J) and x-irradiated (K-M) mice were subjected to automated, quantitative object identification using Squassh3C. Identified objects are highlighted with color hues randomly assigned to individual objects (N-S), Mean object intensity (T) and total object surface (U) were calculated based on all objects, or only those above 50 or 100 pixels in size (V). n = 5, student t-test, * = p<0.05, **=p<0.01, ns = non-significant. Mean ± SEM.
Movie S1. NG2-glia and LepR Processes Intermingle in the ME. Related to Figure 4 . The movie is an animated z stack acquired from a ME section of a LepR-Cre x GFP mouse following immuno-labeling with antibodies against NG2 glia (red) and GFP (green). Z-stack images were acquired by confocal laser microscopy, DAPI nuclear stain is shown in blue. Arrows mark NG2-glia contacting GFP-positive processes.
EXTENDED EXPERIMENTAL PROCEDURES Mice

LepR-Cre (LepRb-IRES-Cre) (DeFalco et al., 2001) or NG2-CreER (NG2creER
TM BAC) (Zhu et al., 2011) mice were crossed with tdTomato (Ai9-lsl-tdTomato) (Madisen et al., 2010) or GFP (ROSA26-CAGS-tauGFP) (Wen et al., 2011) reporter mice to generate LepR-Cre x tdTomato, LepR-Cre x GFP, or NG2-CreER x tdTomato animals. Sox10-iCreERT2 mice (Simon et al., 2012) were crossed with a CAG-eGFP reporter line (Nakamura et al., 2006) and Esco2 fl/fl mice (Whelan et al., 2012) to create Sox10, lox-Esco2 fl/fl , GFP mice which carried a Sox10-iCreERT2 transgene, a GFP reporter allele and which were homozygous for the floxed Esco2 allele. C57BL/6J and ob/ob (B6.Cg-Lepob/J) mice were obtained from Jackson Laboratories.
Viral Injections
For viral injections, LepR-Cre x GFP mice were anesthetized with isoflurane and placed in a stereotaxic frame (Kopf Instruments). 0.3 µl of AAVdj-Ef1α-Flex-ArchT-GFP (Molecular Virology Support Core, Oregon Health and Science University; Addgene plasmid # 58851, (Han et al., 2011) ) was bilaterally injected at a flow rate of 0.05 µl/min using a syringe pump (Harvard apparatus) at the following stereotaxic coordinates: anteroposterior -1.5mm, lateral +/-0.4 mm, dorsoventral -6.1 mm.
X-Irradiation
Mice were anesthetized with KX cocktail and placed into a stereotaxic apparatus, which was then covered by a 1/8" thick lead shield. To target x-irradiation to the mediobasal hypothalamic region of the mouse brain, the exposed skull was covered by a lead sheet that featured a 2 mm diameter bore. The bore was aligned with a marking on the skull that was placed 1.7 mm posterior to bregma. In this setting, only a small tissue column (2 mm diameter) which includes the ME and mediobasal hypothalamus is exposed to the radiation beam while the mouse brain and body remains otherwise shielded. The mouse positioned in the shielded stereotaxic apparatus was then placed into an x-irradiator (Rad Source 2000 Biological Research Irradiator). Animals were exposed to a total of either 45 Gray or 60 Gray in 3 consecutive sessions on alternating days. Per session, animals were irradiated for 7.6 min or 10.10 min to receive a dose of 15 Gray or 20 Gray respectively. Sham-irradiated controls were identically treated, except for the use of an intact, bore-less lead sheet placed above their skulls to prevent irradiation exposure.
Tamoxifen and BrdU Treatment
Tamoxifen (Sigma) was dissolved in a 1:9 (v/v) ethanol:sunflower oil mix to a final concentration of 30 mg/ml. NG2-CreER x tdTomato mice were given an i.p. injection twice daily at a dose of 1.2mg tamoxifen 3 hr after lights on and 1.5mg tamoxifen 1 hr before lights off, for 5 consecutive days. Sox10-Cre, Esco2 fl/fl and Sox10-Cre, Esco2 wt/wt mice were given three times 10 mg tamoxifen in 1:9 (v/v) ethanol:corn oil by gavage every second day (30 mg/mouse in total). For intraperitoneal BrdU (Sigma) delivery, a solution of 6.25 µg/µL BrdU in saline was injected at a dose of 50 mg/kg body weight twice daily, unless otherwise specified. For icv delivery of BrdU in the context of AraC treatment, osmotic minipumps were filled with BrdU (Sigma) in aCSF to provide a dose of 30 µg/day.
Immunohistochemistry
Brain tissue was fixed and processed for immunohistochemical detection as previously described (Robins et al., 2013) . Mice were deeply anesthetized with KX and transcardially perfused with 0.9% NaCl followed by 10% formalin. Brains were removed, postfixed in 10% formalin overnight, and then incubated with a 20% sucrose cryoprotectant solution. 25µm thick coronal sections were cut using a sliding microtome (Leica) and 5 series of sections were collected per brain. For immunohistochemistry, sections were blocked with a solution of 3% goat serum/0.1% triton X-100 in PBS for 1 hr before being incubated with primary antibody in blocking solution at room temperature overnight. Sections containing BrdU underwent an additional antigen retrieval procedure prior to blocking, consisting of either a 10 minute incubation in a 500 U/ml DNase I (Sigma, cat# DN25) solution or a 1 hr incubation in 2N HCl at room temperature. Sections processed for pSTAT3 immunoreactivity were subjected to antigen retrieval treatment consisting of sequential incubation with 1% NaOH + 1% H 2 O 2 (20 minutes), 0.3% glycine (10 minutes) and 0.06% SDS (10 minutes). Phospho-H2A.X labelling included an antigen retrieval step in which sections were incubated for one hour at 80˚C in 10mM sodium citrate buffer (pH 6.0) prior to blocking with 5% goat serum/0.1% triton X-100 in PBS. Primary antibodies were used at the following dilutions: rat monoclonal anti-BrdU (Accurate, cat# OBT00030) 1:500, rabbit polyclonal anti-GFP (Invitrogen, cat# A6544) 1:10,000, goat anti-GFP (Vector Labs, cat# A21271) 1:1000, mouse anti-phospho-histone H2A.X (Millipore, cat# 05-636) 1:700, rabbit polyclonal anti-Iba-1 (Wako, cat#019-19741) 1:500, rabbit polyclonal anti-NG2 (Millipore, cat# AB5320) 1:250, rabbit polyclonal anti-POMC precursor (Phoenix Pharmaceuticals, cat# M9C6) 1:2500, rabbit polyclonal anti-pSTAT3 (Cell Signalling cat# 9131) 1:2000. Alexa350, Alexa488, Alexa568 and Alexa647 conjugates (Life Technologies) were employed as secondary antibodies for fluorescence detection.
Fluorescence Imaging and Data Analysis
Epifluorescent images of brain sections were taken using a Zeiss Axio Image D2 microscope equipped with an AxioCam HRm camera. Confocal images were acquired using the visible laser scanning and spectral descan detection portion of a Carl Zeiss LSM 710 NLO system in conjunction with Zen black edition software (Zeiss). Images were acquired using a 20x dry or 63x oil objective (both Plan-Apochromat, Zeiss) at a resolution of 1600x1600 or 1024x1024 pixels, respectively. Z-stacks encompassing the entire thickness of the tissue slice were acquired at a pinhole size of 1 airy unit with a 50% overlap between adjacent optical sections. Three sections or more per animal were used for quantification, representing anterior, middle and posterior ME regions. Z-stacks were utilized to identify and quantify cells throughout the entire ME region, from the internal zone at the floor of the third ventricle and the base of the arcuate nucleus, to the edge of the external or pericapillary zone containing the fenestrated capillaries. For analysis of GFP+ dendrites following x-irradiation, a region of interest (ROI) encompassing the median eminence was selected from 20x confocal images of GFP, excluding the dorsal region, which contains the cell soma of tanycytes and neurons. The ROI was processed using Squassh3C software (Rizk et al., 2014 ) with a threshold of 0.60 for automated object recognition. Objects with a size greater than 200 pixels were excluded from further (Squassh) analysis, due to concerns that they may represent conglomerations of closely adjacent objects. Data output of the Squassh analysis comprised a list of the automatically identified objects along with their size and fluorescent signal intensities. Statistical differences were calculated using ANOVA. For the quantitative analysis of the immunohistochemical pSTAT3 signal in hypothalamic sections, fluorescence images were processed using a custom macro in Image J. Briefly, ROIs in sections were delineated by identifying objects in the ArcN or VMH above a set threshold; these corresponded to the somas of pSTAT3+ ArcN or VMH cells. Mean intensities of these soma signals were then calculated first for each ROI, and then the mean of all ROIs for each animal was computed.
Ultrastructural Analysis
Obese, AraC-infused LepR-Cre x GFP animals and normal weight (aCSF-infused) controls were perfused 7 weeks post cannulation surgery. Tissue processing and image acquisition was performed according to previously described methods (Stroh et al., 2006) . Mice were deeply anaesthetized using KX and transcardially perfused with 0.9% NaCl followed by 2% paraformaldehyde (PFA)/2% glutaraldehyde (GA). Brains were removed, post-fixed overnight in 2%PFA/2%GA, and the hypothalamic area was cut into 50µm thick coronal sections using a vibratome (1000 Plus Sectioning System, Vibratome) and further processed as described (Stroh et al., 2006) . Sections were immuno-labelled with rabbit anti-GFP antiserum (1:10,000) followed by gold-conjugated goat anti-rabbit IgG (1:50, Aurion ImmunoGold Reagents, Electron Microscopy Sciences) and silver intensification treatment (Aurion R-Gent SE-EM kit, Electron Microscopy Sciences). Ultrathin (90nm), stained sections were imaged by transmission electron microscopy (Tecnai 12 120kV, FEI). Structures containing 3 or more silver grains were considered LepR-GFP positive. Eighteen 4800x images (~100µm 2 each) per animal, representing the ME from the ventricular to the pericapillary zone, were subjected to analysis using Stereo Investigator and Neurolucida Explorer contour analysis software (MBF Bioscience). The number, perimeter and area enclosed by the contours were calculated (summed across all 18 images) and given as ratios of immuno-positive degenerating structures over all immuno-positive structures. Data was presented as mean ratios of sums ± standard error. LepR+ dendrites were classified as degenerating if they manifested two or more of the following previously documented structural aberrations attributed to degenerating neurites: an empty, electron-lucent cytoplasm devoid of organelles (Jaworski et al., 2011; Kaur et al., 2011) , vacuolization (Jaworski et al., 2011; Kaur et al., 2011) , membranous fragments, disintegrated organelles/cytoskeletal elements, dark debris (Adori et al., 2011; Ikonomidou et al., 1996; Jaworski et al., 2011) , abnormal mitochondria with swollen and distended cristae, holes, discontinuous membranes, or an electron-dense burst morphology (Ikonomidou et al., 1996; Siskova et al., 2010) .
